ZIPOLI, VALENTINA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.338
EU - Europa 2.692
AS - Asia 1.709
SA - Sud America 181
OC - Oceania 47
AF - Africa 40
Continente sconosciuto - Info sul continente non disponibili 34
Totale 10.041
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.271
RU - Federazione Russa 850
IT - Italia 645
SG - Singapore 442
CN - Cina 440
HK - Hong Kong 280
SE - Svezia 265
IE - Irlanda 232
VN - Vietnam 185
KR - Corea 152
BR - Brasile 141
PL - Polonia 137
UA - Ucraina 131
DE - Germania 122
FR - Francia 106
FI - Finlandia 85
TR - Turchia 57
GB - Regno Unito 54
IN - India 52
AU - Australia 47
CA - Canada 37
CH - Svizzera 26
MX - Messico 18
AR - Argentina 17
BD - Bangladesh 17
JP - Giappone 15
CI - Costa d'Avorio 11
CZ - Repubblica Ceca 10
IQ - Iraq 10
JO - Giordania 9
SC - Seychelles 9
NL - Olanda 8
CO - Colombia 6
ES - Italia 6
EC - Ecuador 5
ID - Indonesia 5
MA - Marocco 5
PH - Filippine 5
TH - Thailandia 5
VE - Venezuela 5
ZA - Sudafrica 5
AE - Emirati Arabi Uniti 4
IR - Iran 4
NP - Nepal 4
SA - Arabia Saudita 4
AZ - Azerbaigian 3
EU - Europa 3
PK - Pakistan 3
UZ - Uzbekistan 3
AL - Albania 2
AT - Austria 2
BE - Belgio 2
CR - Costa Rica 2
CY - Cipro 2
EG - Egitto 2
HN - Honduras 2
IL - Israele 2
KE - Kenya 2
PA - Panama 2
PE - Perù 2
PY - Paraguay 2
RS - Serbia 2
TT - Trinidad e Tobago 2
AO - Angola 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BJ - Benin 1
BO - Bolivia 1
CL - Cile 1
CV - Capo Verde 1
DK - Danimarca 1
GR - Grecia 1
GT - Guatemala 1
HR - Croazia 1
KW - Kuwait 1
KZ - Kazakistan 1
LY - Libia 1
MD - Moldavia 1
MK - Macedonia 1
MY - Malesia 1
NG - Nigeria 1
NI - Nicaragua 1
OM - Oman 1
PR - Porto Rico 1
PS - Palestinian Territory 1
SK - Slovacchia (Repubblica Slovacca) 1
TN - Tunisia 1
TW - Taiwan 1
UY - Uruguay 1
Totale 10.010
Salva come PNG Salva come JPEG
Città #
Santa Clara 1.105
Fairfield 487
Ashburn 375
Singapore 256
Chandler 247
Dublin 232
Woodbridge 232
Hong Kong 230
Jacksonville 214
Seattle 205
Cambridge 202
Houston 181
Wilmington 167
San Jose 155
Seoul 146
Warsaw 137
Beijing 133
Buffalo 114
Milan 92
Altamura 84
Council Bluffs 81
The Dalles 77
Lawrence 71
Ann Arbor 65
Princeton 65
Hefei 56
Lauterbourg 55
Ho Chi Minh City 51
Hanoi 47
Melbourne 47
Rome 46
Izmir 44
Los Angeles 44
Boardman 43
Dearborn 43
Boston 38
Medford 38
Dallas 33
Mumbai 33
Kent 31
Munich 29
Moscow 28
Paris 25
Bern 23
New York 22
Shanghai 21
Florence 20
Phoenix 20
Columbus 19
Turin 18
Norwalk 17
Naples 16
San Diego 16
Orem 14
São Paulo 13
Abidjan 11
Chicago 11
Helsinki 11
Bologna 10
Genoa 10
Haiphong 10
Tokyo 10
Verona 10
Andover 9
Tianjin 9
Turku 9
Brno 8
Frankfurt Am Main 8
Palermo 8
Washington 8
West Jordan 8
Auburn Hills 7
Bari 7
Brooklyn 7
Da Nang 7
Guangzhou 7
L'aquila 7
Yubileyny 7
Brasília 6
Hillsboro 6
London 6
Miano 6
Queens 6
Shenzhen 6
Toronto 6
Atlanta 5
Brescia 5
Cagliari 5
Charlotte 5
Falls Church 5
Frankfurt am Main 5
Johannesburg 5
Montreal 5
Redondo Beach 5
San Francisco 5
Venice 5
Manchester 4
Pescara 4
Philadelphia 4
Saint Petersburg 4
Totale 6.615
Salva come PNG Salva come JPEG
Nome #
Associazione tra atrofia della sostanza grigia neocorticale e progressione del deficit cognitivo in pazienti con sclerosi multipla recidivante remittente 287
THE RAO'S BRIEF REPEATABLE BATTERY AND STROOP TEST: NORMATIVE VALUES WITH AGE, EDUCATION AND GENDER CORRECTIONS IN AN ITALIAN POPULATION. 250
A short version of Rao's Brief Repeatable Battery as a screening tool for cognitive impairment in multiple sclerosis. 226
Cognitive impairment in early stages of multiple sclerosis. 217
Prevalence of patient-reported dysphagia in multiple sclerosis patients: an Italian multicenter study (using the DYMUS questionnaire). 215
Cognitive impairment and event-related potentials in paediatric multiple sclerosis: 2-year study. 214
BRAIN DAMAGE AS DETECTED BY MAGNETIZATION TRANSFER IMAGING IS LESS PRONOUNCED IN BENIGN THAN IN EARLY RELAPSING MULTIPLE SCLEROSIS. 211
The glycopeptide csf114(glc) detects serum antibodies in multiple sclerosis. 200
Cognitive assessment and quantitative magnetic resonance metrics can help to identify benign multiple sclerosis. 198
Impact of cognitive impairment on coping strategies in multiple sclerosis. 198
Cognitive and psychosocial features in childhood and juvenile MS: two-year follow-up. 198
Cognitive rehabilitation in children and adolescents with multiple sclerosis. 196
Changes in neuropsychological test performance over the workday in multiple sclerosis. 189
ApolipoproteinE epsilon 4 allele is not associated with disease course and severity in multiple sclerosis. 186
NEOCORTICAL VOLUME DECREASE IN RELAPSING-REMITTING MULTIPLE SCLEROSIS WITH MILD COGNITIVE IMPAIRMENT. 185
RESPONSE TO INTERFERON-BETA THERAPY IN RELAPSING-REMITTING MULTIPLE SCLEROSIS: A COMPARISON OF DIFFERENT CLINICAL CRITERIA. 182
BENIGN MULTIPLE SCLEROSIS: COGNITIVE, PSYCHOLOGICAL AND SOCIAL ASPECTS IN A CLINICAL COHORT. 180
Are there protective treatments for cognitive decline in MS? 178
Cognitive and psychosocial features of childhood and juvenile MS. 178
Cognitive impairment in multiple sclerosis. 177
Cognitive changes in multiple sclerosis 174
New natural history of interferon-b treated relapsing multiple sclerosis 173
Psychosocial issue in children and adolescents with multiple sclerosis. 169
Absence of cerebrospinal fluid oligoclonal bands is associated with delayed disability progression in relapsing-remitting MS patients treated with interferon-beta 168
The contribution of cerebrospinal fluid oligoclonal band sto the early diagnosis of multiple sclerosis 167
Cognitive dysfunction in multiple sclerosis: current approaches to clinical management. 165
Multiple sclerosis-related cognitive changes: a review of cross-sectional and longitudinal studies. 164
Subclinical MS. Follow-up of four cases 163
Influence of apolipoprotein E epsilon4 genotype on brain tissue integrity in relapsing-remitting multiple sclerosis. 162
Coping strategies, cognitive impairment, psychological variables and their relationship with quality of life in multiple sclerosis. 158
Immunomodulatory therapies delay disease progression in multiple sclerosis. 153
Reliability, practice effects, and change indices for Rao's Brief Repeatable Battery. 153
Switching to second-line therapies in interferon- beta treated relapsing-remitting multiple sclerosis patients 152
Neocortical volume decrease in relapsing-remitting MS patients with mild cognitive impairment. 147
Interobserver agreement on Poser's and the new McDonald's diagnostic criteria for multiple sclerosis. 145
Safety and tolerability of cyclophosphamide 'pulses' in multiple sclerosis: a prospective study in a clinical cohort. 145
Cortical functional reorganization and its relationship with brain structural damage in patients with benign multiple sclerosis. 145
Neuropsychological and MRI measures predict short-term evolution in benign multiple sclerosis 142
The brief neuropsychological battery for children: a screening tool for cognitive impairment in childhood and juvenile multiple sclerosis. 142
Intravenous mitoxantrone and cyclophosphamide as second-line therapy in multiple sclerosis: an open-label comparative study of efficacy and safety. 141
Long-term adherence to interferon beta therapy in relapsing-remitting multiple sclerosis 139
Coping strategies, psychological variables and their relationship with quality of life in multiple sclerosis. 138
The harlequin sign: case report and MRI findings 138
Cognitive and psychiatric disorders in multiple sclerosis 137
APOE-{epsilon}4 is not associated with cognitive impairment in relapsing--remitting multiple sclerosis. 136
Relevance of cognitive deterioration in early relapsing-remitting MS: a 3-year follow-up study. 135
Clinical management of cognitive impairment in multiple sclerosis: a review of current evidence. 131
Cognitive dysfunction and mood disorders in multiple sclerosis, Blue Book of Practical Neurology: Multiple sclerosis and related CNS inflammatory demylinating disorders, Editors: CF Lucchinetti and R Hohlfeld., in press 128
Gray matter atrophy correlates with MS disability progression measured with MSFC but not EDSS. 126
Multiple sclerosis in Italy: cost-of-illness study. 123
Costi di malattia: revisione degli studi italiani 119
Early prediction of the long-term evolution of multiple sclerosis: the BREMS score 116
Long-term adherence to interferon beta therapy in relapsing-remitting multiple sclerosis. 116
Evidence for relative cortical sparing in benign multiple sclerosis: a longitudinal magnetic resonance imaging study. 112
Real-life impact of early interferon beta therapy in relapsing multiple sclerosis. 112
New natural history of interferon -beta-treated relapsig multiple sclerosis . Reply 110
Disturbi somatoformi 107
Riso e pianto spastico 103
Depressione 97
Correlati clinici 95
Psicosi 90
La sclerosi multipla 86
Disturbi bipolari 86
Storia naturale 85
Profilo del deficit 83
Totale 10.041
Salva come PNG Salva come JPEG
Categoria #
all - tutte 28.174
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 28.174
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022363 0 0 32 11 9 13 27 20 11 11 133 96
2022/20231.108 114 215 34 89 86 197 160 53 100 3 27 30
2023/2024313 26 39 58 18 22 19 8 53 2 16 39 13
2024/20252.596 78 247 141 349 848 459 14 111 144 59 78 68
2025/20262.452 287 352 170 133 269 100 290 167 150 103 45 386
2026/2027418 65 102 251 0 0 0 0 0 0 0 0 0
Totale 10.041